COMPARING MOLECULAR EFFECTS OF VARIOUS CYTOPROTECTORS IN COMPLEX THERAPY OF CORONARY HEART DISEASE

The molecular effects of trimetazidine and mildronate were investigated in patients with stable effort angina, Functional Class (FC) I-III. The comparison criteria included blood activity and concentrations of the main products of free-radical oxidation and the components of Krebs cycle and anti-oxi...

Full description

Bibliographic Details
Main Author: E. A. Kartashova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2009-10-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1390
_version_ 1797857162514399232
author E. A. Kartashova
author_facet E. A. Kartashova
author_sort E. A. Kartashova
collection DOAJ
description The molecular effects of trimetazidine and mildronate were investigated in patients with stable effort angina, Functional Class (FC) I-III. The comparison criteria included blood activity and concentrations of the main products of free-radical oxidation and the components of Krebs cycle and anti-oxidant system. Proteomic methods were also used. Trimetazidine and mildronate could be recommended as cardio-protectors in primary and secondary prevention of FC I-III coronary heart disease.
first_indexed 2024-04-09T20:52:09Z
format Article
id doaj.art-701ff734ab2745afa9a0b2eed03c8197
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2024-04-09T20:52:09Z
publishDate 2009-10-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-701ff734ab2745afa9a0b2eed03c81972023-03-29T21:23:16Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202009-10-010562671179COMPARING MOLECULAR EFFECTS OF VARIOUS CYTOPROTECTORS IN COMPLEX THERAPY OF CORONARY HEART DISEASEE. A. Kartashova0Ростовский государственный медицинский университет, Ростов-на-ДонуThe molecular effects of trimetazidine and mildronate were investigated in patients with stable effort angina, Functional Class (FC) I-III. The comparison criteria included blood activity and concentrations of the main products of free-radical oxidation and the components of Krebs cycle and anti-oxidant system. Proteomic methods were also used. Trimetazidine and mildronate could be recommended as cardio-protectors in primary and secondary prevention of FC I-III coronary heart disease.https://russjcardiol.elpub.ru/jour/article/view/1390coronary heart diseasefree-radical oxidationcytochemistryproteomicstrimetazidinemildronate
spellingShingle E. A. Kartashova
COMPARING MOLECULAR EFFECTS OF VARIOUS CYTOPROTECTORS IN COMPLEX THERAPY OF CORONARY HEART DISEASE
Российский кардиологический журнал
coronary heart disease
free-radical oxidation
cytochemistry
proteomics
trimetazidine
mildronate
title COMPARING MOLECULAR EFFECTS OF VARIOUS CYTOPROTECTORS IN COMPLEX THERAPY OF CORONARY HEART DISEASE
title_full COMPARING MOLECULAR EFFECTS OF VARIOUS CYTOPROTECTORS IN COMPLEX THERAPY OF CORONARY HEART DISEASE
title_fullStr COMPARING MOLECULAR EFFECTS OF VARIOUS CYTOPROTECTORS IN COMPLEX THERAPY OF CORONARY HEART DISEASE
title_full_unstemmed COMPARING MOLECULAR EFFECTS OF VARIOUS CYTOPROTECTORS IN COMPLEX THERAPY OF CORONARY HEART DISEASE
title_short COMPARING MOLECULAR EFFECTS OF VARIOUS CYTOPROTECTORS IN COMPLEX THERAPY OF CORONARY HEART DISEASE
title_sort comparing molecular effects of various cytoprotectors in complex therapy of coronary heart disease
topic coronary heart disease
free-radical oxidation
cytochemistry
proteomics
trimetazidine
mildronate
url https://russjcardiol.elpub.ru/jour/article/view/1390
work_keys_str_mv AT eakartashova comparingmoleculareffectsofvariouscytoprotectorsincomplextherapyofcoronaryheartdisease